Analysis of Humanized Mouse Models for Cancer Immunotherapy Studies

Philippe De La Rochere's study provides a detailed comparison of two humanized immune system mouse models for preclinical immunotherapy evaluation. The research assesses immune cell engraftment kinetics, graft-versus-host disease, and tumor responses to T-cell-directed therapies. The dataset was published as a PDF on figshare in April 2026.

Use Cases

• Compare engraftment kinetics and quality between Hu-CD34+ and Hu-PBMC models described in the study.
• Analyze the impact of different immunodeficient host mouse strains on immune cell reconstitution for the Hu-CD34+ model.
• Investigate distinct immune-tumor interactions and antitumor responses from tumors derived from cell lines versus patient-derived xenografts.
• Evaluate variations in tumor responses to specific T-cell-directed therapies like anti-PD1 antibodies and IL-2-anti-IL-2 antibody complexes across models.

Strengths

• Directly compares two widely used humanized mouse models (Hu-CD34+ and Hu-PBMC) with specific experimental results.
• Investigates tumor responses to multiple specific therapies: anti-PD1, IL-2-anti-IL-2 complexes, and T-cell engagers.
• Published under a permissive CC-BY-4.0 license allowing reuse and redistribution.

Limitations

• The dataset is a 2.0 MB PDF document, not structured data, requiring manual extraction for computational analysis.
• Sample sizes, row counts, and specific numerical metrics for experiments are not provided in the metadata.
• Temporal coverage of the underlying experimental data is unspecified.

Provenance

Source

Philippe De La Rochere via figshare.

Collection Method

Experimental study comparing humanized mouse models engrafted with human tumors and hematopoietic cells.

Time Range

null

Freshness

Last updated in April 2026, indicating recent publication.

Geography

null